The 22nd China International Laboratory Medicine & Transfusion Instruments and Reagents Expo (CACLP 2025) concluded successfully on March 24th at the Hangzhou Grand Convention & Exhibition Center, bringing together 1,300+ exhibitors from 23 countries and 100,000+ professionals under the theme of innovation and global healthcare advancement.
YZY MED showcased its self-developed full-suite solutions at CACLP 2025, highlighting its leading R&D capabilities in in vitro diagnostics. Key exhibits included:
- Cardiovascular pharmacogenomics products
- Oncology companion diagnostics
- CTCBIOPSY D200 (integrated cell separation & staining system)
- F902 FISH automated slide processing system
At this conference, YZY MED showcased a comprehensive solution for FISH experiments, including pretreatment kits, open automated equipment, and multiplex probe panels. Among them, the fully automated slide processing system F902 is a truly open fully automated instrument. The system features an integrated operation platform, realizing full-process automation for FISH experiments such as slide baking, probe dispensing, coverslip application and removal, and DAPI staining through an integrated intelligent sensing system. With 10 independent testing stations, it reduces the need for multiple instruments. During operation, the F902 system can process 1-6 different probes in the same batch, suitable for diverse sample types including tissues, blood, and urine. Additionally, the system is compatible with most commercially available FISH probe reagents, achieving true openness of the automated platform.
2025 CACLP, YZY MED ‘s brand recognition is further enhanced, CTC Separator is highly sought after. YZY MED has made extensive strategic layout in circulating tumor cell (CTC) detection. Based on the compact and portable Cell Separator A10, YZY MED has newly developed the automated Cell Separation and Staining All-in-One system D200, which integrates CTC enrichment and staining processes to achieve true end-to-end automation for CTC isolation and staining. This system works seamlessly with standard optical microscopes to enable slide analysis and report generation. The D200 supports simultaneous and independent blood sample processing for up to 6 specimens, requiring no manual intervention once loaded, while its innovative design allows parallel handling of multiple samples. Leveraging patented nano-micro sieve technology, it ensures efficient capture of CTCs without compromise. With the D200, processing 6 samples for both separation and staining takes only 50 minutes, significantly reducing costs.
This grand event has successfully come to an end, yet the innovation journey of YZY MED will never stop. In the face of the increasingly upgraded diagnostic demands, YZY MED will set its sights firmly on the development goals, march forward with determination, and continue to deepen its efforts. With its outstanding products, it will empower clinical diagnosis and treatment, contribute to the development of precision medicine, and inject strong impetus into the soaring of the in vitro diagnostic industry.
